You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
|
|---|---|
| Published in |
Molecular Cancer, October 2014
|
| DOI | 10.1186/1476-4598-13-228 |
| Pubmed ID | |
| Authors |
Renaud Sabatier, Pascal Finetti, Arnaud Guille, José Adelaide, Max Chaffanet, Patrice Viens, Daniel Birnbaum, François Bertucci |
| Abstract |
The lastly identified claudin-low (CL) subtype of breast cancer (BC) remains poorly described as compared to the other molecular subtypes. We provide a comprehensive characterization of the largest series of CL samples reported so far. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 238 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | <1% |
| Denmark | 1 | <1% |
| France | 1 | <1% |
| Brazil | 1 | <1% |
| Unknown | 234 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 64 | 27% |
| Student > Master | 37 | 16% |
| Researcher | 30 | 13% |
| Student > Bachelor | 29 | 12% |
| Student > Doctoral Student | 13 | 5% |
| Other | 24 | 10% |
| Unknown | 41 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 70 | 29% |
| Biochemistry, Genetics and Molecular Biology | 62 | 26% |
| Medicine and Dentistry | 33 | 14% |
| Pharmacology, Toxicology and Pharmaceutical Science | 12 | 5% |
| Nursing and Health Professions | 5 | 2% |
| Other | 13 | 5% |
| Unknown | 43 | 18% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 October 2014.
All research outputs
#14,201,538
of 22,765,347 outputs
Outputs from Molecular Cancer
#903
of 1,719 outputs
Outputs of similar age
#131,115
of 253,586 outputs
Outputs of similar age from Molecular Cancer
#19
of 36 outputs
Altmetric has tracked 22,765,347 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1,719 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 43rd percentile – i.e., 43% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 253,586 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 36 others from the same source and published within six weeks on either side of this one. This one is in the 44th percentile – i.e., 44% of its contemporaries scored the same or lower than it.